Inside the post-compounding GLP-1 market: pharma’s pivot, DTC’s ceiling, and payer infrastructure at scale.
After the Gold Rush: What Comes Next for…
Inside the post-compounding GLP-1 market: pharma’s pivot, DTC’s ceiling, and payer infrastructure at scale.